+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2026 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 80 Pages
  • Global
From
Diabetic Retinopathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Polycythemia Vera - Pipeline Insight, 2026 - Product Thumbnail Image

Polycythemia Vera - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Postpartum Depression - Pipeline Insight, 2026 - Product Thumbnail Image

Postpartum Depression - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Spinocerebellar Ataxias - Pipeline Insight, 2026 - Product Thumbnail Image

Spinocerebellar Ataxias - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Adenosine Antagonist - Pipeline Insight, 2026 - Product Thumbnail Image

Adenosine Antagonist - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 80 Pages
  • Global
From
Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 450 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2026 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Pre-Eclampsia - Pipeline Insight, 2026 - Product Thumbnail Image

Pre-Eclampsia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Myotonic Dystrophy - Pipeline Insight, 2026 - Product Thumbnail Image

Myotonic Dystrophy - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 80 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis - Pipeline Insight, 2026 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 280 Pages
  • Global
From
Benlysta Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Benlysta Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Tocilizumab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Tocilizumab Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
OFEV Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

OFEV Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
ENDARI Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

ENDARI Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
TREMFYA Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

TREMFYA Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more